29 reports

  • Erythropoietin: An overview
  • First-generation erythropoietin formulation
  • Erythropoietin
  • China
  • Forecast
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.

Introduction to Erythropoietin ##. ## An Introduction to Erythropoietin ##. ##. ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Market Size
  • Global erythropoietin drugs market
  • ERYTHROPOIETIN DRUGS MARKET IN JAPAN 2014-2019 ($ MILLIONS)
  • Erythropoietin
  • Japan
  • Chugai Pharmaceutical Co., Ltd.
  • Kissei Pharmaceutical Co., Ltd.
  • Kyowa Hakko Kirin Co., Ltd.

Erythropoietin Drug Market Outlook, By Region (2014-2022) ($MN) Table ## Global Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN) Table ## Global Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN) Table ## Global Erythropoietin Drug M

  • Erythropoietin
  • Asia
  • Europe
  • World
  • Forecast

Erythropoietin Market - Introduction ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Market Size

In addition, major players of the erythropoietin drug, along with their upcoming and anticipated erythropoietin-related products are analyzed to demonstrate how these advances might impact global erythropoietin drug market.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Forecast

European Erythropoietin Market Outlook 2022 ##.

  • Biopharmaceutical
  • Erythropoietin
  • Europe
  • Market Size

This enables Biocon to enhance its erythropoietin drugs portfolio.

  • Biopharmaceutical
  • Erythropoietin
  • Forecast

Global Erythropoietin Market Outlook 2020 ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Forecast
  • Market Size
  • Erythropoietin: An overview
  • Global erythropoietin market
  • Erythropoietin
  • China
  • Market Size
  • 3SBio Inc.
  • Kyowa Hakko Kirin Co., Ltd.

Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others.............. ## Biosimilars.............. ## Table ##: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown

  • Erythropoietin
  • Infectious Disease
  • World
  • Market Shares
  • Market Size

Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S. A., and Others.............. ## Table ##: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for ##SBio, Inc., Beijing Four Rings Biopharmac

  • Erythropoietin
  • China
  • World
  • Demand
  • Market Shares

Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S. A., and Others.............. ## Table ##: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for ##SBio, Inc., Beijing Four Rings Biopharmac

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Demand
  • Market Shares

Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others.............. ## Biosimilars.............. ## Table ##: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown

  • Erythropoietin
  • United States
  • World
  • Demand
  • Market Shares
  • 1.1 ERYTHROPOIETIN
  • ERYTHROPOIETIN RESPONSE TO HYPOXIA
  • Erythropoietin
  • Asia
  • World
  • Market Size
  • Roche Group

MARKET OVERVIEW.............. ## Therapeutic Biologics.............. ## Table ##: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antib

  • Biopharmaceutical
  • Erythropoietin
  • China
  • United States
  • Market Shares

The drug consists of recombinant human erythropoietin and targets the erythropoietin receptor, initiating the same pathway as native erythropoietin and triggering increased blood production in bone marrow (EMC, 2017).

  • Biopharmaceutical
  • Erythropoietin
  • Europe
  • Japan
  • Demand

Drug Analysis: Mircera

9091 10000 7727

Mircera is administered by intravenous or subcutaneous injection, and targets the erythropoietin receptor, initiating the same pathway as native erythropoietin and triggering increased blood production in bone marrow.

  • Biopharmaceutical
  • Blood Disease
  • Erythropoietin
  • Europe
  • Japan
  • 8.4 ERYTHROPOIETIN (EPO)
  • PEGYLATED PROTEINS MARKET SIZE FOR ERYTHROPOIETIN, BY REGION, 2014-2021 (USD MILLION)
  • Erythropoietin
  • Interferon
  • North America
  • World
  • JenKem Technology Co., Ltd
  • ERYTHROPOIETIN - DRUG PROFILE
  • PEGYLATED ERYTHROPOIETIN - DRUG PROFILE
  • Chronic Disease
  • Erythropoietin
  • United States
  • World
  • Product Initiative
  • ERYTHROPOIETIN - DRUG PROFILE
  • PEGYLATED ERYTHROPOIETIN - DRUG PROFILE
  • Chronic Disease
  • Erythropoietin
  • Japan
  • United States
  • Product Initiative
  • Clinical Trial profile. 7 Trial Title
  • Clinical Trial profile. 9 Trial Title
  • Blood Disease
  • Clinical Trial
  • Erythropoietin
  • Therapy
  • Amgen Inc.
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## Nov 2002 ## Jan 2006 ## ## ## Erythropoietin Receptor (EPOR) Agonist Erythropoietin Receptor (EPOR) Evaluation of the Therapeutic Equivalence of Two Different Formulations Containing Epoetin (Epoetin Stada Vs.

  • Blood Disease
  • Clinical Trial
  • Erythropoietin
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • Official Title
  • Official Title
  • Blood Disease
  • Clinical Trial
  • Erythropoietin
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • BBT-009
  • Bolder Biotechnology, Inc. - Preclinical, 2016
  • Erythropoietin
  • R&D
  • Research And Development
  • United States
  • Bolder BioTechnology, Inc.
  • EPOETIN ALFA - DRUG PROFILE
  • PEG-EPO - DRUG PROFILE
  • Blood Disease
  • Erythropoietin
  • United States
  • Product Initiative
  • FibroGen, Inc.
  • ERYTHROPOIETIN MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE ERYTHROPOIETIN
  • Erythropoietin
  • Proteomics
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.

Drug Analysis: Aranesp

9091 10000 7727

The drug targets the erythropoietin receptor, initiating the same pathway as native erythropoietin, and triggering increased blood production in bone marrow.

  • Biopharmaceutical
  • Erythropoietin
  • Europe
  • Japan
  • Product Initiative
  • Product Description
  • Intas Pharmaceuticals Ltd. - Phase III, 2015
  • Erythropoietin
  • Therapy
  • World
  • Product Initiative
  • Intas Pharmaceuticals Ltd.